glp 1 drugs with insurance Comparing Ozempic, Wegovy and Other GLP-1 Insurance companies scrambling to support

A new study based on real world data found a possible protective effect against multiple sclerosis for some of new weight loss medications.

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD

GLP-1 RAs have gained attention for treating obesity and type 2 diabetes (T2DM), largely due to their ability to reduce gastric motility

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

The oral version must be taken in a special way - it should be taken after fasting overnight, with a small amount of water (no more than half a cup)